Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (41-50 of 323) with videos related to

Pageof 33
Sort By:
Current Opinion in Urology|August 18, 2016
Minimally invasive approaches to adrenal tumors: an up-to-date summary including patient position and port placement of laparoscopic, retroperitoneoscopic, robot-assisted, and single-site adrenalectomyMarie C Hupe, Florian Imkamp, Axel S Merseburger
Expert Review of Molecular Diagnostics|October 23, 2015
Recent progress in urinary proteome analysis for prostate cancer diagnosis and managementMaria Frantzi, Agnieszka Latosinska, Axel S Merseburger, et al.
Oncotargets and Therapy|December 13, 2016
Androgen deprivation therapy as backbone therapy in the management of prostate cancerAxel S Merseburger, Antonio Alcaraz, Christoph A von Klot
Frontiers of Radiation Therapy and Oncology|June 12, 2008
Secondary hormonal manipulationAxel S Merseburger, Claus Belka, Klaus Behmenburg, et al.
World Journal of Urology|April 14, 2026
Unresolved questions in the sequencing of systemic therapy for advanced urothelial carcinomaPrasanna Ram, Axel S Merseburger, Matchima Huabkong, et al.
World Journal of Urology|May 10, 2013
How far is the horizon? From current targets to future drugs in advanced renal cancerStephan Kruck, Axel S Merseburger, Arnulf Stenzl, et al.
World Journal of Urology|September 17, 2009
Considerations on prostate cancer: diagnosis and treatment decisionsThomas R W Herrmann, Axel S Merseburger, Martin Burchardt
World Journal of Urology|October 27, 2010
Prostate cancer: novel aspects of diagnostics and surgical technologyThomas R W Herrmann, Axel S Merseburger, Martin Burchardt
Journal of Comparative Effectiveness Research|December 19, 2014
Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulationsAxel S Merseburger, Thomas Björk, James Whitehouse, et al.
Diagnostics (Basel, Switzerland)|August 31, 2018
Promise and Implementation of Proteomic Prostate Cancer BiomarkersAgnieszka Latosinska, Maria Frantzi, Axel S Merseburger, et al.
Pageof 33

Showing results (41-50 of 323) with videos related to

Sort By:
Pageof 33
Current Opinion in Urology|August 18, 2016
Minimally invasive approaches to adrenal tumors: an up-to-date summary including patient position and port placement of laparoscopic, retroperitoneoscopic, robot-assisted, and single-site adrenalectomyMarie C Hupe, Florian Imkamp, Axel S Merseburger
Expert Review of Molecular Diagnostics|October 23, 2015
Recent progress in urinary proteome analysis for prostate cancer diagnosis and managementMaria Frantzi, Agnieszka Latosinska, Axel S Merseburger, et al.
Oncotargets and Therapy|December 13, 2016
Androgen deprivation therapy as backbone therapy in the management of prostate cancerAxel S Merseburger, Antonio Alcaraz, Christoph A von Klot
Frontiers of Radiation Therapy and Oncology|June 12, 2008
Secondary hormonal manipulationAxel S Merseburger, Claus Belka, Klaus Behmenburg, et al.
World Journal of Urology|April 14, 2026
Unresolved questions in the sequencing of systemic therapy for advanced urothelial carcinomaPrasanna Ram, Axel S Merseburger, Matchima Huabkong, et al.
World Journal of Urology|May 10, 2013
How far is the horizon? From current targets to future drugs in advanced renal cancerStephan Kruck, Axel S Merseburger, Arnulf Stenzl, et al.
World Journal of Urology|September 17, 2009
Considerations on prostate cancer: diagnosis and treatment decisionsThomas R W Herrmann, Axel S Merseburger, Martin Burchardt
World Journal of Urology|October 27, 2010
Prostate cancer: novel aspects of diagnostics and surgical technologyThomas R W Herrmann, Axel S Merseburger, Martin Burchardt
Journal of Comparative Effectiveness Research|December 19, 2014
Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulationsAxel S Merseburger, Thomas Björk, James Whitehouse, et al.
Diagnostics (Basel, Switzerland)|August 31, 2018
Promise and Implementation of Proteomic Prostate Cancer BiomarkersAgnieszka Latosinska, Maria Frantzi, Axel S Merseburger, et al.
Pageof 33